Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGS - Nasdaq Real Time Price USD

CG Oncology, Inc. (CGON)

Compare
22.05
-2.44
(-9.96%)
At close: April 1 at 4:00:01 PM EDT
22.24
+0.19
+(0.86%)
After hours: April 1 at 6:44:28 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,139
1,139
204
191
10,358
Operating Expense
115,805
115,805
55,653
35,437
22,964
Operating Income
-114,666
-114,666
-55,449
-35,246
-12,606
Net Non Operating Interest Income Expense
26,624
26,624
6,904
-1
-451
Other Income Expense
3
3
-62
-196
218
Pretax Income
-88,039
-88,039
-48,607
-35,443
-12,839
Net Income Common Stockholders
-88,039
-88,039
-67,798
-43,788
-18,383
Diluted NI Available to Com Stockholders
-88,039
-88,039
-67,798
-43,788
-18,383
Basic EPS
-15.87
-1.41
-1.07
-11.71
-0.55
Diluted EPS
-15.87
-1.41
-1.07
-11.71
-0.55
Basic Average Shares
67,537.86
62,496.73
63,482.51
3,740.89
33,699.98
Diluted Average Shares
67,537.86
62,496.73
63,482.51
3,740.89
33,699.98
Total Operating Income as Reported
-114,666
-114,666
-55,449
-35,246
-12,606
Total Expenses
115,805
115,805
55,653
35,437
22,964
Net Income from Continuing & Discontinued Operation
-88,039
-88,039
-48,607
-35,443
-12,839
Normalized Income
-88,039
-88,039
-48,607
-35,443
-12,839
Interest Income
26,624
26,624
6,904
--
--
Interest Expense
--
--
--
1
451
Net Interest Income
26,624
26,624
6,904
-1
-451
EBIT
-114,666
-114,666
-55,449
-35,246
-12,388
EBITDA
-114,634
-114,634
-55,432
-35,231
-12,378
Reconciled Depreciation
32
32
17
15
10
Net Income from Continuing Operation Net Minority Interest
-88,039
-88,039
-48,607
-35,443
-12,839
Normalized EBITDA
-114,634
-114,634
-55,432
-35,231
-12,378
12/31/2021 - 1/25/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AVBP ArriVent BioPharma, Inc.
18.03
-2.49%
 
ACLX Arcellx, Inc.
60.70
-7.47%
 
CNTA Centessa Pharmaceuticals plc
13.23
-8.00%
 
ENGN enGene Holdings Inc.
4.3300
-3.35%
 
IDYA IDEAYA Biosciences, Inc.
14.77
-9.83%
 
UPB Upstream Bio, Inc.
6.70
+9.48%
 
MAZE Maze Therapeutics, Inc.
9.90
-10.08%
 
NAMS NewAmsterdam Pharma Company N.V.
18.38
-10.21%
 
MLTX MoonLake Immunotherapeutics
36.35
-6.96%
 
RAPP Rapport Therapeutics, Inc.
9.56
-4.69%